FDA
approval
· 2021-02-12
FDA Approved: METOPROLOL SUCCINATE — Original Application (Epic Pharma, LLC)
Summary
FDA approves the original application for metoprolol succinate as a generic extended-release beta-blocker indicated for hypertension and heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for METOPROLOL SUCCINATE (METOPROLOL SUCCINATE)